Kloss M W, Patrick D H, MacDonald J S
Department of Safety Assessment, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.
Food Chem Toxicol. 1991 Sep;29(9):621-8. doi: 10.1016/0278-6915(91)90144-v.
A novel class of hypocholesterolaemic agents, HMG CoA reductase inhibitors, was shown to cause mucosal thickening in the rodent (mouse and rat) forestomach after subacute/subchronic oral administration. These changes were characterized histologically by acanthosis and hyperkeratosis of the squamous epithelium with submucosal oedema and occasionally cellular infiltration. This drug-induced hyperplastic response was both dose and time dependent, did not occur after subcutaneous administration, and was confined entirely to the rodent forestomach (not observed in any other area of the gastro-intestinal tract). The forestomach hyperplastic response correlated with the pharmacological potency of HMG CoA reductase inhibitors of similar structure (observed to varying degrees with all HMG CoA reductase inhibitors examined to date).
一类新型的降胆固醇药物,即HMG CoA还原酶抑制剂,经亚急性/亚慢性口服给药后,在啮齿动物(小鼠和大鼠)的前胃中会导致黏膜增厚。这些变化在组织学上的特征为鳞状上皮的棘皮症和角化过度,伴有黏膜下水肿,偶尔还有细胞浸润。这种药物诱导的增生反应具有剂量和时间依赖性,皮下给药后不会出现,并且完全局限于啮齿动物的前胃(在胃肠道的任何其他部位均未观察到)。前胃增生反应与结构相似的HMG CoA还原酶抑制剂的药理活性相关(迄今为止,在所检测的所有HMG CoA还原酶抑制剂中均观察到不同程度的反应)。